Major drug companies reach landmark $26bn US opioid settlement

Drug manufacturer Johnson & Johnson and three distributors have agreed to pay $26bn to resolve thousands of claims over their role in the US opioid epidemic.
State and local governments brought the lawsuits which accused the companies of helping drive a nationwide deadly opioid epidemic.
US pharmaceutical distributors, McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp, are to pay a total of $21bn; while Johnson & Johnson is expected to pay $5bn.
The crisis has taken about half a million US residents’ lives.

Al Jazeera’s Gabriel Elizondo reports from New York, the US.

– Subscribe to our channel:
– Follow us on Twitter:
– Find us on Facebook:
– Check our website:

#USOpioidCrisis #JohnsonandJohnson #OpioidCrisis

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *